Glaxosmithkline reported 1.82B in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Amgen AMGN:US $ 2176M 324M
AstraZeneca AZN:LN 2.2B 673M
Aurora Cannabis Inc ACB:CN C$ -110537000 13M
Bristol Myers Squibb BMY:US $ 3197M 9M
Canopy Growth Corp WEED:CN -114437000 194.91M
Catalent CTLT:US $ 216M 38M
Corcept Therapeutics CORT:US $ 31.43M 4.66M
Eli Lilly And LLY:US $ 1650.5M 919.4M
GlaxoSmithKline GSK:LN 1.82B 600M
Glaxosmithkline GSK:US 1.82B 600M
Horizon Pharma HZNP:US 147M 49.44M
JAZZ PHA JAZZ:US 126.35M 38.8M
Johnson & Johnson JNJ:US $ 6941M 599M
Lannett LCI:US $ -20301000 2.47M
Merk MRK:US $ 5711M 652M
Novartis NOVN:VX 3.32B 176M
Pacira Pharmaceuticals PCRX:US $ 13.18M 8.55M
Perrigo Ordinary Shares PRGO:US $ 2.6M 20.5M
Pfizer PFE:US $ 12099M 2104M
Phibro Animal Health PAHC:US $ 19.19M 3.1M
Prestige Brands PBH:US $ 87.01M 9.59M
Supernus Pharmaceuticals SUPN:US $ 11.35M 9.38M
Takeda 4502:JP 150.52B 152.13B
Teva Pharmaceutical TEVA:IT 734M 55M
Valeant Pharmaceuticals VRX:CN C$ 368.14M 60.14M
Zoetis ZTS:US $ 737M 57M